The Latest: Moderna beefs up manufacturing for 2021-22 doses

CAMBRIDGE, Mass. — Moderna announced Thursday it is beefing up global manufacturing of its COVID-19 vaccine in an effort to produce up to 3 billion doses in 2022.

The company predicts supplying between 800 million and 1 billion doses worldwide this year. But it’s looking ahead as much of the world still will need a first round of COVID-19 vaccinations next year — and to be ready if and when people may need a booster shot.

Moderna’s vaccine is authorized for use by adults in the U.S., European Union and multiple other countries. The company expects data soon from a U.S. study of the two-dose vaccine in 12- to 17-year-olds, and has begun testing the shots in younger children. Also underway are studies of doses tweaked to better match a worrisome mutated version of the coronavirus.

___

THE VIRUS OUTBREAK:

— Biden declared “America is rising anew” as he called for expanding programs to drive economy past pandemic

— India sets another record with 375K new cases as it gears up to expand vaccinations to all adults

— As many as one-third of Mexicans may have been exposed to virus in 2020

— Some Californians can’t get vaccine despite surge in supply

— Follow more of AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic and https://apnews.com/hub/coronavirus-vaccine

___

HERE’S WHAT ELSE IS HAPPENING:

MANILA, Philippines — The Philippines is extending an already monthlong lockdown by two weeks as the country’s worst coronavirus infection spike starts to ease but remains alarming.

President Rodrigo Duterte said in televised remarks Thursday night that the second-most...